Skip to main content
See every side of every news story
Published loading...Updated

Why CytomX Therapeutics Stock Was Skyrocketing This Week @themotleyfool #stocks $CTMX

Summary by The Motley Fool
Key PointsAn analyst initiated coverage on the biotech, and how.She feels it could more than double in price from current levels.10 stocks we like better than CytomX Therapeutics › It isn't difficult for a modestly priced stock to leap in value on a positive news item. That's the dynamic behind the monster rise these past few days of clinical-stage biotech CytomX Therapeutics (NASDAQ: CTMX). An analyst initiated coverage of the cancer-focused dr…

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Motley Fool broke the news in Alexandria, United States on Friday, September 26, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal